Detall de la convocatòria

Característiques

Característica
Objectiu de la convocatòria
This grant supports early-career investigators to pursue neuroendocrine cancer research and commit to the field. Projects must be led by a single principal investigator, with or without collaborators, and include two aims to be completed within a two-year timeframe.
Característiques principals
  • Research Areas of Interest
    - Early Detection: Approaches to identify neuroendocrine cancer at earlier, more treatable stages, including biomarker and assay development, imaging, and risk prediction models.
    - New Therapeutic Development: Discovery and advancement of innovative treatments, such as targeted therapies, immunotherapies, and novel modalities.
    - Precision Medicine: Strategies to match therapies to individual patients based on tumor biology, biomarkers, and disease characteristics.

  • Tumor Types:
    Neuroendocrine neoplasms (NENs) across sites and stages, including well-differentiated neuroendocrine tumors (G1–G3) and poorly differentiated extrapulmonary neuroendocrine carcinoma (epNEC), including metastatic, unknown primary, and hereditary cases (e.g., MEN1, VHL, NF1, SDHx) when NEN biology is central. MiNEN are eligible when the neuroendocrine component is biologically or clinically driving; neuroendocrine features within other primary cancer types are not eligible.

    A complete list of eligible NEN types and out-of-scope tumor types is provided in the guidelines.
    • Lloc de presentació
    HMRIB and PSMAR staff who need more information should contact:
    Research Grants and Contracts Office. C/ Doctor Aiguader, 88. 08003 Barcelona. Tel.: 93.316.04.00.
    Carol Barnwell: [email protected] Ext.: 1670
    Marta López: [email protected] Ext.: 1576
    Júlia Vidal: [email protected] Ext.: 1736
    Convocatòria (URL)
    https://netrf.org/for-researchers/about/funding-for-researchers/mentored-research-grants/
    Informació addicional
    This call follows a two-step procedure. Letters of intent must be submitted through the Proposal Central platform by 5:00 PM ET on the deadline date.
    Requisits
  • Applicants must hold an MD, PhD, MD/PhD, or equivalent degree and must not currently be a candidate for any additional doctoral or professional degree.
  • Applicants must hold a full-time, mentored research position (e.g., postdoctoral fellow, clinical research fellow, instructor, or equivalent). Assistant Professors within the first three years of their initial faculty appointment may also be eligible, provided they remain in a mentored career stage with a designated mentoring committee.
  • Applicants must conduct their research under the supervision of a mentor at an academic, medical, or research institution in the U.S. or abroad and be focused on establishing expertise in neuroendocrine cancer research. Fully independent investigators or those holding substantial independent funding (e.g., R01-equivalent) are not eligible.
  • Eligible organizations include public or private institutions, such as universities, colleges, hospitals, and laboratories, both within and outside of the United States. Applications from the biotech, pharmaceutical, or for-profit life sciences industries are not eligible.
  • The award may be transferred during the first year of a junior faculty appointment, subject to NETRF approval and continued eligibility.
    • Dotació
    $150,000
    Durada
    2 years

    Arxius

    Arxiu
    MRA-RFA-Final-2026-v2.pdf